326 related articles for article (PubMed ID: 13680083)
1. Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats.
Bertoglio LJ; Carobrez AP
Psychopharmacology (Berl); 2003 Dec; 170(4):335-42. PubMed ID: 13680083
[TBL] [Abstract][Full Text] [Related]
2. NMDA and D1 receptors are involved in one-trial tolerance to the anxiolytic-like effects of diazepam in the elevated plus maze test in rats.
Zhou H; Yu CL; Wang LP; Yang YX; Mao RR; Zhou QX; Xu L
Pharmacol Biochem Behav; 2015 Aug; 135():40-5. PubMed ID: 26004015
[TBL] [Abstract][Full Text] [Related]
3. Scopolamine given pre-Trial 1 prevents the one-trial tolerance phenomenon in the elevated plus-maze Trial 2.
Bertoglio LJ; Carobrez AP
Behav Pharmacol; 2004 Feb; 15(1):45-54. PubMed ID: 15075626
[TBL] [Abstract][Full Text] [Related]
4. Effects of NMDA receptor blockade during the early development period on the retest performance of adult Wistar rats in the elevated plus maze.
Kocahan S; Akillioglu K
Neurochem Res; 2013 Jul; 38(7):1496-500. PubMed ID: 23619560
[TBL] [Abstract][Full Text] [Related]
5. Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze.
Bertoglio LJ; Carobrez AP
Pharmacol Biochem Behav; 2002 May; 72(1-2):449-55. PubMed ID: 11900819
[TBL] [Abstract][Full Text] [Related]
6. Anxiolytic activity of glycine-B antagonists and partial agonists--no relation to intrinsic activity in the patch clamp.
Karcz-Kubicha M; Jessa M; Nazar M; Plaznik A; Hartmann S; Parsons CG; Danysz W
Neuropharmacology; 1997 Oct; 36(10):1355-67. PubMed ID: 9423923
[TBL] [Abstract][Full Text] [Related]
7. Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus maze.
Bertoglio LJ; Carobrez AP
Pharmacol Biochem Behav; 2002 Nov; 73(4):963-9. PubMed ID: 12213543
[TBL] [Abstract][Full Text] [Related]
8. Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice.
Wiley JL; Cristello AF; Balster RL
Eur J Pharmacol; 1995 Dec; 294(1):101-7. PubMed ID: 8788421
[TBL] [Abstract][Full Text] [Related]
9. Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam.
Albrechet-Souza L; Cristina de Carvalho M; Rodrigues Franci C; Brandão ML
Horm Behav; 2007 Aug; 52(2):267-73. PubMed ID: 17553501
[TBL] [Abstract][Full Text] [Related]
10. The anterior cingulate cortex is a target structure for the anxiolytic-like effects of benzodiazepines assessed by repeated exposure to the elevated plus maze and Fos immunoreactivity.
Albrechet-Souza L; Borelli KG; Carvalho MC; Brandão ML
Neuroscience; 2009 Dec; 164(2):387-97. PubMed ID: 19699782
[TBL] [Abstract][Full Text] [Related]
11. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.
Gomes KS; Nunes-De-Souza RL
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1261-9. PubMed ID: 19625008
[TBL] [Abstract][Full Text] [Related]
12. A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia.
Albrechet-Souza L; Oliveira AR; De Luca MC; Tomazini FM; Santos NR; Brandão ML
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):571-9. PubMed ID: 15866360
[TBL] [Abstract][Full Text] [Related]
13. Enhanced dorsolateral periaqueductal gray activity counteracts the anxiolytic response to midazolam on the elevated plus-maze Trial 2 in rats.
Bertoglio LJ; Anzini C; Lino-de-Oliveira C; Carobrez AP
Behav Brain Res; 2005 Jul; 162(1):99-107. PubMed ID: 15922070
[TBL] [Abstract][Full Text] [Related]
14. Effects of dizocilpine-induced glutamatergic blockade in the nucleus accumbens septi on the plus maze test.
Gargiulo API; Gargiulo De Aranda MP; Gargiulo MML; Gargiulo AJM; Acuña A; Baiardi GC; Lafuente JV; Landa De Gargiulo AI; Guevara MA; Gargiulo PA
J Basic Clin Physiol Pharmacol; 2018 Jun; 29(3):241-246. PubMed ID: 29902911
[TBL] [Abstract][Full Text] [Related]
15. Termination of pseudopregnancy in the rat alters the response to progesterone, chlordiazepoxide, and MK-801 in the elevated plus-maze.
Bitran D; Solano SM
Psychopharmacology (Berl); 2005 Jul; 180(3):447-54. PubMed ID: 15700179
[TBL] [Abstract][Full Text] [Related]
16. Similar anxiolytic-like effects following intra-amygdala infusions of benzodiazepine receptor agonist and antagonist: evidence for the release of an endogenous benzodiazepine inverse agonist in mice exposed to elevated plus-maze test.
Barbalho CA; Nunes-de-Souza RL; Canto-de-Souza A
Brain Res; 2009 Apr; 1267():65-76. PubMed ID: 19268657
[TBL] [Abstract][Full Text] [Related]
17. The dorsal periaqueductal gray modulates the increased fear-like behavior exhibited by experienced rats in the elevated plus-maze.
Kincheski GC; Carobrez AP
Behav Brain Res; 2010 Jan; 206(1):120-6. PubMed ID: 19737580
[TBL] [Abstract][Full Text] [Related]
18. One-trial tolerance to the effects of chlordiazepoxide in the elevated plus-maze is not due to acquisition of a phobic avoidance of open arms during initial exposure.
Frussa-Filho R; Ribeiro Rde A
Life Sci; 2002 Jun; 71(5):519-25. PubMed ID: 12052436
[TBL] [Abstract][Full Text] [Related]
19. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats.
Przegaliński E; Tatarczyńska E; Chojnacka-Wójcik E
Neuropharmacology; 2000 Jul; 39(10):1858-64. PubMed ID: 10884566
[TBL] [Abstract][Full Text] [Related]
20. NMDA/glutamate mechanism of magnesium-induced anxiolytic-like behavior in mice.
Poleszak E; Wlaź P; Wróbel A; Fidecka S; Nowak G
Pharmacol Rep; 2008; 60(5):655-63. PubMed ID: 19066411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
